Upload File

The top documents tagged [ecog ps]

Stereotactic Ablative RT in HCC
Stereotactic Ablative RT in HCC
951 views
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO conference
Colorectal Cancer Research & Treatment News - recap from the May 2014 ASCO conference
375 views
A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid Tumors Anthony W. Tolcher, 1 Timothy A. Yap, 2 Ivy
A Phase I Study of MK-2206, an Oral Potent Allosteric Akt Inhibitor in Patients with Advanced Solid Tumors Anthony W. Tolcher, 1 Timothy A. Yap, 2 Ivy
216 views
Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives Moderator: Ashley Grossman, MD, FRCP Professor of Neuroendocrinology
Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives Moderator: Ashley Grossman, MD, FRCP Professor of Neuroendocrinology
215 views
II-SDV 2014 Development of Reports and Visualisations to Facilitate the Analysis and Transformation of the Clinical Trial Landscape into Actionable Intelligence (Diane Webb - Bizint,
II-SDV 2014 Development of Reports and Visualisations to Facilitate the Analysis and Transformation of the Clinical Trial Landscape into Actionable Intelligence (Diane Webb - Bizint,
478 views
Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
Talimogene laherparepvec (T-VEC, OncoVEX GM-CSF) phase 3 data in melanoma presented at virotherapy symposium Oxford, April 2014
1.427 views
07 state of the art of the management of advanced and recurrent ovarian cancer
07 state of the art of the management of advanced and recurrent ovarian cancer
440 views
Pfizer at Lehman Brothers Global Health Care Conference
Pfizer at Lehman Brothers Global Health Care Conference
1.022 views
FOLFOXIRI plus bevacizumab (bev) vs FOLFIRI plus bev as 1st-line treatment of metastatic colorectal cancer: results of the phase III randomized TRIBE trial
FOLFOXIRI plus bevacizumab (bev) vs FOLFIRI plus bev as 1st-line treatment of metastatic colorectal cancer: results of the phase III randomized TRIBE trial
219 views
1. DLBCL of the elderly in age older than life expectancy the single institute experience in Taiwan Sheng Hsuan,Chien, MD Division of Hematology and Oncology,
1. DLBCL of the elderly in age older than life expectancy the single institute experience in Taiwan Sheng Hsuan,Chien, MD Division of Hematology and Oncology,
216 views
A pooled analysis of the final results of the two randomized phase II studies comparing Gemcitabine (G) vs Gemcitabine + Docetaxel (G+D) in patients (pts)
A pooled analysis of the final results of the two randomized phase II studies comparing Gemcitabine (G) vs Gemcitabine + Docetaxel (G+D) in patients (pts)
218 views
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis,
217 views